Results for: drugmaker

Actavis, Sanofi among bidders for Omega Pharma- Bloomberg

Shire CFO to leave drugmaker as AbbVie drops bid

AbbVie says $55 billion acquisition of Shire officially dead

Pfizer's $11 billion buyback plan deflates AstraZeneca bid hopes

Novartis reports positive results in spinal inflammation condition

Drugmakers may need indemnity for fast-tracked Ebola vaccines

GSK sees first Ebola vaccine doses ready late this year

Roche to spend $3.2 billion on towering Basel base

Hikma Pharma shares slip on FDA warning for Portugal plant

Exclusive - EU earmarks $250 million to help develop Ebola vaccines:...

FTSE 100 rebounds, GKN gains after results

Fixing 'Ebolanomics' in pursuit of vaccines and drugs

AbbVie says $55 billion acquisition of Shire officially dead

Private equity eyes 10 billion-euro Bayer plastics business - sources

J&ampJ and GSK step up Ebola vaccine race

Drug companies step up Ebola vaccine race

U.S. stocks drop AT&ampT earns miss

WHO says Ebola vaccine plans accelerating as trials advance